These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39032511)

  • 41. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA; Al Omari A; Murry DJ; Case D
    Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010).
    Britton BM; Kelleher ME; Gregor TP; Sorenmo KU
    Vet Comp Oncol; 2014 Dec; 12(4):266-76. PubMed ID: 22998454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
    Tan AR; Wright GS; Thummala AR; Danso MA; Popovic L; Pluard TJ; Han HS; Vojnović Ž; Vasev N; Ma L; Richards DA; Wilks ST; Milenković D; Yang Z; Antal JM; Morris SR; O'Shaughnessy J
    Lancet Oncol; 2019 Nov; 20(11):1587-1601. PubMed ID: 31575503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
    Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
    J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of automated versus manual neutrophil counts for the detection of cellular abnormalities in dogs receiving chemotherapy: 50 cases (May to June 2008).
    Cora MC; Neel JA; Grindem CB; Kissling GE; Hess PR
    J Am Vet Med Assoc; 2013 Jun; 242(11):1539-43. PubMed ID: 23683019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
    Kelly K; Pan Z; Murphy J; Huffman DH; Bunn PA
    Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
    Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
    J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer.
    Ikesue H; Watanabe H; Hirano M; Chikamori A; Suetsugu K; Ryokai Y; Egashira N; Yamada T; Ikeda M; Iwama E; Harada T; Takayama K; Nakanishi Y; Masuda S
    Biol Pharm Bull; 2015; 38(8):1192-8. PubMed ID: 26235582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?
    Kim JJ; Park JY; Kim DY; Kim JH; Kim YM; Nam JH; Kim YT
    Acta Obstet Gynecol Scand; 2010 May; 89(5):623-8. PubMed ID: 20423275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers.
    Chon HS; Kang S; Lee JK; Apte SM; Shahzad MM; Williams-Elson I; Wenham RM
    BMC Cancer; 2017 Jun; 17(1):407. PubMed ID: 28595616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
    Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
    J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carboplatin.
    Fox LE
    J Am Anim Hosp Assoc; 2000; 36(1):13-4. PubMed ID: 10667400
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam.
    Eichstadt LR; Moore GE; Childress MO
    Vet Comp Oncol; 2017 Dec; 15(4):1346-1353. PubMed ID: 27714960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
    Li S; Huang H; Liao H; Zhan J; Guo Y; Zou BY; Jiang WQ; Guan ZZ; Yang XQ
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):96-105. PubMed ID: 23127487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
    Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
    Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum granulocyte colony-stimulating factor (G-CSF) and interleukin-1 (IL-1) concentrations after chemotherapy-induced neutropenia in normal and tumor-bearing dogs.
    Bravo L; Legendre AM; Hahn KA; Rohrbach BW; Abraha T; Lothrop CD
    Exp Hematol; 1996 Jan; 24(1):11-7. PubMed ID: 8536786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
    Smallwood K; Tanis JB; Grant IA; Blackwood L; Killick DR; Amores-Fuster I; Elliott J; Mas A; Harper A; Marrington M; Finotello R
    Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrospective Evaluation of a Combination of Carboplatin and Bleomycin for the Treatment of Canine Carcinomas.
    Giuliano A; Almendros A
    Animals (Basel); 2022 Sep; 12(18):. PubMed ID: 36139200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.